CORE Biomedicine
Latest round
- Series A
Last raised
- Jul 2026
Total raised
- $21M
Investors
- 9
About CORE Biomedicine
, develops innovative therapies targeting core lineage pathways essential for tumor survival, aiming to advance treatment options for oncology patients. Founded in 2022 and based in Massachusetts, US, CORE Biomedicine, Inc. focuses on creating therapies that address key mechanisms in tumor survival. The company was co-founded by Ping Zhu (CEO) and Douglas McMillin. In July 2026, CORE Biomedicine, Inc. CORE Biomedicine, Inc. specializes in developing therapies that focus on core lineage pathways critical for tumor survival and aim to disrupt dysfunctional cell signaling linked to tumor growth, specifically for luminal cancers such as bladder, pancreatic, gastric, and colorectal tumors. Their products are geared towards clinical settings in North America and Asia, targeting healthcare providers for oncology patients. CORE Biomedicine, Inc. generates revenue through strategic partnerships and collaborations with pharmaceutical and biotechnology sectors, utilizing a lineage therapy-based drug discovery platform. Its business transactions typically include licensing agreements and clinical trial partnerships, yielding upfront payments, milestone payments, and royalties from product sales post-commercialization.
Who invested in CORE Biomedicine
9 investors across 2 rounds
See all investors in CORE Biomedicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CORE Biomedicine
Who invested in CORE Biomedicine?
CORE Biomedicine has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CORE Biomedicine raised?
CORE Biomedicine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CORE Biomedicine last raise money?
CORE Biomedicine's most recent round on record is a Series A, in Jul 2026.
What does CORE Biomedicine do?
, develops innovative therapies targeting core lineage pathways essential for tumor survival, aiming to advance treatment options for oncology patients.
Where is CORE Biomedicine headquartered?
CORE Biomedicine is headquartered in Allston, US.
Which VCs invest in companies like CORE Biomedicine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CORE Biomedicine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CORE Biomedicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.